Patents by Inventor Sylvain TOUREL

Sylvain TOUREL has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20220370555
    Abstract: The invention relates to a fusion protein containing a selective cell death-inducing enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use.
    Type: Application
    Filed: March 13, 2018
    Publication date: November 24, 2022
    Applicant: SIT Biotech GmbH
    Inventors: Sylvain TOUREL, Tabea KRĂ„FT
  • Publication number: 20190105378
    Abstract: The invention relates to a combination preparation containing a selective cell death-inducing binary enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use.
    Type: Application
    Filed: November 19, 2018
    Publication date: April 11, 2019
    Applicant: SIT - SOFT INTELLIGENT THERAPEUTICS GMBH & CO. KG (Claus Simandi)
    Inventor: Sylvain TOUREL
  • Publication number: 20170199197
    Abstract: The invention relates to a method for diagnosing cancer and use thereof, in particular for providing profiles and use thereof.
    Type: Application
    Filed: May 29, 2015
    Publication date: July 13, 2017
    Applicant: ABA GMBH & CO. KG
    Inventor: Sylvain TOUREL
  • Publication number: 20160038573
    Abstract: The invention relates to a combination preparation containing a selective cell death-inducing binary enzyme system for use in the therapy and/or treatment of cancer and tumors in humans and animals, a process, and its use.
    Type: Application
    Filed: January 17, 2014
    Publication date: February 11, 2016
    Applicant: SIT-Soft Intelligent Therapeutics GmbH & Co. KG
    Inventor: Sylvain TOUREL